Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: Results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A)

Journal of the American College of Cardiology

Volumn 60, Issue 25, 2012, Pages 2683-2692

  Reynolds, Matthew R ^a,b   Magnuson, Elizabeth A ^c,d   Lei, Yang ^c,e   Wang, Kaijun ^c   Vilain, Katherine ^c   Li, Haiyan ^c   Walczak, Joshua ^a   Pinto, Duane S ^l   Thourani, Vinod H ^f   Svensson, Lars G ^g   MacK, Michael J ^h   Miller, D Craig ⁱ   Satler, Lowell E ^j   Bavaria, Joseph ^k   Smith, Craig R ^m   Leon, Martin B ^m   Cohen, David J ^c,d  

^a HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h Heart Hospital Baylor   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j WASHINGTON HOSPITAL CENTER   (United States)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

^l BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^m Department of Orthopaedic Surgery   (United States)

more..

Author keywords

aortic valve replacement; cost effectiveness; TAVR

Indexed keywords

AGED; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; FEMALE; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COST-BENEFIT ANALYSIS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 84871301406     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.09.018     Document Type: Article

References (24)

1. M.B. Leon, C.R. Smith, M. Mack Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
2. M.R. Reynolds, E.A. Magnuson, Y. Lei Health related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis Circulation 124 2011 1964 1972
3. M.R. Reynolds, E.A. Magnuson, K. Wang Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (Cohort B) Circulation 125 2012 1102 1109
4. C.R. Smith, M.B. Leon, M.J. Mack Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
5. S.K. Kodali, M.R. Williams, C.R. Smith Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 2012 1686 1695
6. M.R. Reynolds, E.A. Magnuson, K. Wang Health-related quality of life after transcatheter or surgical aortic valve replacement in high risk patients with severe aortic stenosis: results from the PARTNER trial (cohort A) J Am Coll Cardiol 60 2012 548 558
7. D.J. Cohen, A. Bakhai, C. Shi Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial Circulation 110 2004 508 514 (Pubitemid 39031165)
8. D.J. Cohen, H.M. Krumholz, C.A. Sukin In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty Results from a randomized clinical trial. Stent Restenosis Study Investigators Circulation 92 1995 2480 2487
9. D.A. Taira, T.B. Seto, R. Siegrist, R. Cosgrove, R. Berezin, D.J. Cohen Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials Am Heart J 145 2003 452 458 (Pubitemid 36390491)
10. Centers for Medicare and Medicaid Services 100% MedPAR Inpatient Hospital National Data for Fiscal Year 2008: Short Stay Inpatient Diagnosis Related Groups http://www.cms.gov/MedicareFeeforSvcPartsAB/03-MEDPAR.asp#TopOfPage Accessed April 11, 2010
11. J. Mitchell, R. Burge, A. Lee, N.T. McCall Per Case Prospective Payment for Episodes of Hospital Care 1995 US Department of Commerce National Technical Information Service Springfield, VA
12. J.W. Shaw, J.A. Johnson, S.J. Coons US valuation of the EQ-5D health states: development and testing of the D1 valuation model Med Care 43 2005 203 220 (Pubitemid 40353904)
13. W.S. Weintraub, P. Barnett, S. Chen Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial Am Heart J 151 2006 1180 1185 (Pubitemid 43866611)
14. D. Polsky, H. Glick Costing and cost analysis in randomized controlled trials: caveat emptor Pharmacoeconomics 27 2009 179 188
15. U.S. Food and Drug Administration 2012 Meeting Materials of the Circulatory System Devices Panel http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/ MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM308356.pdf June 13, 2012 Accessed June 26, 2012
16. B. Efron An Introduction to the Bootstrap 1993 Chapman & Hall New York, NY
17. B.A. van Hout, M.J. Al, G.S. Gordon, F.F. Rutten Costs, effects, and C/E-ratios alongside a clinical trial Health Econ 3 1994 309 319
18. W.F. Fearon, B. Bornschein, P.A.L. Tonino Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease Circulation 122 2010 2545 2550
19. H. Gada, S.R. Kapadia, E.M. Tuzcu, L.G. Svensson, T.H. Marwick Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients Am J Cardiol 109 2012 1326 1333
20. O.O. Alli, J.D. Booker, R.J. Lennon, K.L. Greason, C.S. Rihal, D.R. Holmes Jr Transcatheter aortic valve implantation: assessing the learning curve J Am Coll Cardiol Intv 5 2012 72 79
21. Dewey TM, Thourani VH, Bavaria JE, et al. Transapical aortic-valve replacement for critical aortic stenosis: results from the nonrandomized continued-access cohort of the PARTNER trial. Paper presented at: Society of Thoracic Surgeons 2012 Annual Meeting; January 30, 2012; Ft. Lauderdale, FL.
22. R.A. Guyton The Placement of Aortic Transcatheter Valve (PARTNER) trial Circulation 125 2012 3237 3239
23. R. Gurvitch, D.A. Wood, E.L. Tay Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort Circulation 122 2010 1319 1327
24. N.E. Moat, P. Ludman, M.A. de Belder Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry J Am Coll Cardiol 58 2011 2130 2138